Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.
D000328:Adult; D019072:Antibiotic Prophylaxis; D000995:Antitubercular Agents / Q000627:therapeutic use / Q000633:toxicity*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D015658:HIV Infections / Q000150:complications; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use / Q000633:toxicity*; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis; D015819:Substance Abuse, Intravenous / Q000150:complications*; D000637:Transaminases / Q000097:blood; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*